These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 38981660)
1. Prevalence of therapeutic use exemptions at the Olympic Games and Paralympic Games: an analysis of data from 2016 to 2022. Vernec A; Healy D; Banon T; Petroczi A Br J Sports Med; 2024 Sep; 58(17):966-972. PubMed ID: 38981660 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018. Vernec A; Healy D Br J Sports Med; 2020 Aug; 54(15):920-924. PubMed ID: 32376674 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012. Fitch KD Br J Sports Med; 2013 Sep; 47(13):815-8. PubMed ID: 23591601 [TBL] [Abstract][Full Text] [Related]
4. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games. Stuart M; Kwon YI; Rhie SJ Br J Sports Med; 2019 Sep; 53(17):1105-1110. PubMed ID: 30894336 [TBL] [Abstract][Full Text] [Related]
5. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions. Overbye M; Wagner U Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632 [TBL] [Abstract][Full Text] [Related]
6. Investigation of supplement use and knowledge among Japanese elite athletes for the Tokyo 2020 Olympic/Paralympic games and the Beijing 2022 winter Olympic/Paralympic games. Myoenzono K; Yasuda J; Takai E; Shinagawa A; Kaneko N; Yoshizaki T; Namma-Motonaga K; Yoshino M; Kondo E; Nakajima K; Hangai M; Kamahara K; Kamihigashi E; Kusano S; Kamei A Front Sports Act Living; 2023; 5():1258542. PubMed ID: 37927448 [TBL] [Abstract][Full Text] [Related]
7. Methods, challenges and benefits of a health monitoring programme for Norwegian Olympic and Paralympic athletes: the road from London 2012 to Tokyo 2020. Clarsen B; Steffen K; Berge HM; Bendiksen F; Fossan B; Fredriksen H; Gjelsvik H; Haugvad L; Kjelsberg M; Ronsen O; Torgalsen T; Walløe A; Bahr R Br J Sports Med; 2021 Dec; 55(23):1342-1349. PubMed ID: 34039584 [TBL] [Abstract][Full Text] [Related]
8. Patterns of Athlete Medication Use at the 2018 PyeongChang Paralympic Games: A Descriptive Cohort Study. Alexander LAJ; Eken MM; Teoh CS; Stuart MC; Derman EW; Blauwet CA Am J Phys Med Rehabil; 2022 Mar; 101(3):270-278. PubMed ID: 33782274 [TBL] [Abstract][Full Text] [Related]
9. Compliance with needle-use declarations at two Olympic Winter Games: Sochi (2014) and PyeongChang (2018). Schobersberger W; Blank C; Budgett R; Pipe A; Stuart MC Br J Sports Med; 2020 Jan; 54(1):27-32. PubMed ID: 31203198 [TBL] [Abstract][Full Text] [Related]
10. High incidence of injuries at the Pyeongchang 2018 Paralympic Winter Games: a prospective cohort study of 6804 athlete days. Derman W; Runciman P; Jordaan E; Schwellnus M; Blauwet C; Webborn N; Lexell J; van de Vliet P; Kissick J; Stomphorst J; Lee YH; Kim KS Br J Sports Med; 2020 Jan; 54(1):38-43. PubMed ID: 30796104 [TBL] [Abstract][Full Text] [Related]
11. Incidence of injury and illness among paediatric Team USA athletes competing in the 2020 Tokyo and 2022 Beijing Olympic and Paralympic Games. Post EG; Anderson T; Shilt JS; Dugan EL; Clark SC; Larson EG; Noble-Taylor KE; Robinson DM; Donaldson AT; Finnoff JT; Adams WM BMJ Open Sport Exerc Med; 2023; 9(4):e001730. PubMed ID: 38143720 [TBL] [Abstract][Full Text] [Related]
12. High incidence of injury at the Sochi 2014 Winter Paralympic Games: a prospective cohort study of 6564 athlete days. Derman W; Schwellnus MP; Jordaan E; Runciman P; Van de Vliet P; Blauwet C; Webborn N; Willick S; Stomphorst J Br J Sports Med; 2016 Sep; 50(17):1069-74. PubMed ID: 27307272 [TBL] [Abstract][Full Text] [Related]
13. Expanding the screening toolbox to promote athlete health: how the US Olympic & Paralympic Committee screened for health problems in 940 elite athletes. Nabhan D; Lewis M; Taylor D; Bahr R Br J Sports Med; 2021 Feb; 55(4):226-230. PubMed ID: 33020138 [TBL] [Abstract][Full Text] [Related]
14. Development and application of PyeongChang 2018 Winter Olympic and Paralympic Games Accessibility Manual. Lee HL; Kim JY; Kim JB Disabil Rehabil Assist Technol; 2021 May; 16(4):391-397. PubMed ID: 32419539 [TBL] [Abstract][Full Text] [Related]
15. The incidence and patterns of illness at the Sochi 2014 Winter Paralympic Games: a prospective cohort study of 6564 athlete days. Derman W; Schwellnus MP; Jordaan E; Runciman P; Van de Vliet P; Blauwet C; Webborn N; Willick S; Stomphorst J Br J Sports Med; 2016 Sep; 50(17):1064-8. PubMed ID: 27162232 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic Use Exemptions. Gerrard D; Pipe A Med Sport Sci; 2017; 62():55-67. PubMed ID: 28571022 [TBL] [Abstract][Full Text] [Related]
17. [Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008]. Thevis M; Hemmersbach P; Geyer H; Schänzer W Med Klin (Munich); 2009 Dec; 104(12):918-24. PubMed ID: 20039158 [TBL] [Abstract][Full Text] [Related]
18. Injuries and illness of athletes at the Tokyo 2020 Olympic and Paralympic summer games visiting outside facilities. Sakanashi S; Tanaka H; Yokota H; Otomo Y; Masuno T; Nakano K; Inoue J; Sugita M; Tokunaga T; Kato N; Kinoshi T; Inoue H; Numata H; Nakagawa K; Sagisaka R; Tanaka S; Miyamoto T; Akama T Sports Med Health Sci; 2024 Mar; 6(1):48-53. PubMed ID: 38463667 [TBL] [Abstract][Full Text] [Related]
19. Eye care and ocular findings at the Olympic and Paralympic Games Rio 2016. Lima VL; Fernandes AG; Viana RG; Feder D Br J Sports Med; 2020 Apr; ():. PubMed ID: 32241820 [TBL] [Abstract][Full Text] [Related]
20. Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes. Fitch K Clin Med (Lond); 2012 Jun; 12(3):257-60. PubMed ID: 22783779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]